View drug registration information details.


ItemsRegistration information
ID302
No302
Brand NameDIFLUVID
IngredientsFLUCONAZOLE 150 MG
Dosage FormCAPSULE
Primary PackagingBLISTERPACK
StorageSTORE BELOW 30"C
Shelf Life3 YEARS
Pack Size4 CAPSULE/BOX
Dispensing CategoryPrescription only
ATC ClassificationG01AG01
Pharmaceutical ClassANTIFUNGAL
Indications- MUCOSAL CANDIDIASIS. THESE INCLUDE OROPHARYNGEAL, ESOPHAGEAL, NON INVASIVE BRONCHOPULMONARY INFECTIONS, CANDIDURIA, - GENITAL CANDIDIASIS : VAGINAL CANDIDIASIS, ACUTE OR RECURRENT AND PROPHYLAXIS TO REDUCE THE INCIDENCE OF RECURRENT VAGINAL CANDIDIASIS
ContraindicationsFLUCONAZOLE SHOULD NOT BE USED IN PATIENTS WITH KNOWN SENSITIVITY TO THE DRUG, ANY OF THE INERT INGREDIENTS OR TO RELATED AZOLE COMPOUNDS.
Side EffectsINCREASED RISK OF EXFOLIATIVE SKIN DISORDERS , INCLUDING STEVENS - JOHNSON SYNDROM, AGRANULOCYTOSIS AND THROMBOCYTOPENNIA.
Unit Price1.48
EDL Yes
DescriptionLIGHT TURQUOISE OPAQUE/LIGHT TURQUOISE OPAQUE CAPSULE WITH "HOVID" PRINTED ON ONE END AND "FL 150"PRINTED ON THE OTHER END OF THE CAPSULE. THE CAPSULE IS FILLED WITH WHITE TO OFF - WHITE POWDER.
Note
License OwnerBMS PHARMA SOLE CO.,LTD
ManufacturerHOVID BHD
CountryMALAYSIA
Import Registration NoMAL09072798AZ
Import Registration Date2014-07-31
ActivityCERTIFICATE RELEASED
Applied Date2023-03-31
FDD Registration No02 I 4211/17
FDD Registration Date2023-06-07
Expiry Date2026-06-06

Back to drug list